Saturday, April 13, 2024
wellness India Expo
Home Tags MRNA

Tag: mRNA

Medicine has to be practiced as a team science: Prof....

Former President of the Public Health Foundation of India presented medical degrees to UG & PG students of Apollo Medical College

Nobel Prize for scientists whose research was critical to develop mRNA...

The Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications

India’s first mRNA based Omicron-specific booster vaccine from Gennova gets DCGI...

The Omicron specific mRNA vaccine will be available under the name - GEMCOVAC®-OM. The intradermal vaccine is stable at 2-8 °C and is administered using a needle-free device

Merck Study: mRNA technology a ‘Game Changer’ for Asia-Pacific vaccine manufacturers

More than 60% vaccine makers surveyed plan revamp or new facilities for mRNA manufacturing to meet demand

Ultragenyx’s UX053 Phase I/II study termination a minor setback for mRNA...

The study was terminated due to reasons unrelated to safety concerns, although the specific rationale has not been disclosed by the biopharmaceutical company

BioAsia 2023 confers Genome Valley Excellence Award upon Professor Robert S....

Langer, the David H. Koch Institute Professor at MIT and co-founder of Moderna, is awarded for his pioneering research work that led to the commericialization of mRNA vaccine

Cipla & Ethris partner for the development of mRNA-based therapies

The definitive agreements for equity investment of EUR 15 million in Ethris GmbH will fast-track Cipla’s participation in the mRNA space

BioVoice eMagazine December 2022 Issue 3 Volume 3

Click to Read: BioVoice eMagazine December 2022 Issue 3 Volume 3 The Cover Story in the current edition focuses on India's strong biotech R&D segment...

Study unveils protein synthesis in red blood cells

A research team led by Sandeep M Eswarappa, Associate Professor, Department of Biochemistry, Indian Institute of Science, Bengaluru, has identified that mature human RBCs can also make their proteins

CEPI and SK bioscience partner to advance mRNA vaccine technology

CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus